Genomatica Looking to Raise $150M

6/15/11

Claiming another milestone on its path to commercialization, San Diego-based Genomatica says it has successfully used a 13,000-liter fermentation tank in Decatur, IL, to produce what it calls a “demonstration-scale” batch of 1,4-Butanediol (BDO), which was previously synthesized through industrial chemical processes. Genomatica said it produced the “Bio-BDO” with partner Tate & Lyle and expects to be in commercial production in late 2012. The real news, however, came Monday when CEO Christophe Schilling told Reuters that Genomatica plans to raise as much as $150 million, possibly through an initial public offering.

Bruce V. Bigelow is the editor of Xconomy San Diego. You can e-mail him at bbigelow@xconomy.com or call (619) 669-8788 Follow @

By posting a comment, you agree to our terms and conditions.